PharMerica Corporation (NYSE:PMC) reported its financial results for the second quarter and six months ended June 30, 2014. Revenues for the second quarter of 2014 were $448.6 million compared with $430.8 million for the second quarter of 2013. The increase in revenue was primarily the result of the fourth quarter 2013 acquisitions and branded drug price inflation, and was partially offset by previously disclosed bed losses as of December 31, 2013. PharMerica Corporation (NYSE:PMC) belongs to Services sector. Its net profit margin is -0.40% and weekly performance is -0.85%. On last trading day company shares ended up $25.60. PharMerica Corporation (NYSE:PMC) distance from 50-day simple moving average (SMA50) is -7.56%.

On 12 AUG Array BioPharma, Inc. (NASDAQ:ARRY) announced its earnings results on Tuesday. The company reported ($0.22) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.23) by $0.01. Array BioPharma, Inc. (NASDAQ:ARRY) shares moved down -1.06% in last trading session and ended the day at $3.74. ARRY Gross Margin is -9.30% and its return on assets is -59.50%. Array BioPharma, Inc. (NASDAQ:ARRY) quarterly performance is -8.78%.

On 18 AUG Mobile Mini, Inc. (NASDAQ:MINI) said that it will begin trading ex-dividend. A cash dividend payment of $0.17 per share is scheduled to be paid on September 03, 2014. Shareholders who purchased MINI stock prior to the ex-dividend date are eligible for the cash dividend payment. This marks the 3rd quarter that MINI has paid the same dividend. At the current stock price of $40.32, the dividend yield is 1.69%. On 23 August, Mobile Mini, Inc. (NASDAQ:MINI) shares moved down -0.77% and was closed at $39.92. MINI EPS growth in last 5 year was -12.90%. Mobile Mini, Inc. (NASDAQ:MINI) year to date (YTD) performance is -1.87%.

On 6 AUG Genocea Biosciences, Inc. (NASDAQ:GNCA) last announced its earnings results on Wednesday. The company reported ($0.41) earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.42) by $0.01. Analysts expect that Genocea Biosciences will post $-2.10 earnings per share for the current fiscal year. Genocea Biosciences, Inc. (NASDAQ:GNCA) ended the last trading day at $13.46. Company weekly volatility is calculated as 9.61%and price to cash ratio as 3.97. Genocea Biosciences, Inc. (NASDAQ:GNCA) showed a weekly performance of 1.74%.

On 13 AUG Health Care REIT, Inc. (NYSE:HCN) said it would buy Canada’s HealthLease Properties Real Estate Investment Trust in a deal valued at $950 million, including debt, to expand its presence in senior housing and post-acute care segments. Health Care REIT, Inc. (NYSE:HCN) shares moved down -0.36% in last trading session and ended the day on $66.13. HCN Gross Margin is 57.40% and its return on assets is 0.70%. Health Care REIT, Inc. (NYSE:HCN) quarterly performance is 3.80%.